Extended lymph node dissection: Bladder, kidney

Current Opinion in Urology

Volumn 21, Issue 2, 2011, Pages 110-114

  Zehnder, Pascal ^a   Desai, Mihir ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

bladder cancer; extended lymph node dissection; renal cell carcinoma; upper urinary tract urothelial carcinoma

Indexed keywords

ARTICLE; BLADDER CANCER; CYSTECTOMY; FROZEN SECTION; HUMAN; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; NEPHROURETERECTOMY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 79951675847     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283430abd     Document Type: Article

References (37)

1. Autenrieth M, Nawroth R, Semmlack S, et al. Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes. Urologe A 2008; 47:1157-1161.
2. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982; 128:34-36. (Pubitemid 12048751)
3. Karl A, Carroll PR, Gschwend JE, et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 2009; 55:826-835.
4. Dhar NB, Klein EA, Reuther AM, et al. Outcome after radical cystectomywith limited or extended pelvic lymph node dissection. J Urol 2008; 179:873-878; discussion 878.
5. Shirotake S, Kikuchi E, Matsumoto K, et al. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer. Jpn J Clin Oncol 2010; 40:247-251.
6. Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167:1295-1298. (Pubitemid 34132073)
7. Roth B, Wissmeyer MP, Zehnder P, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010; 57:205-211.
8. Vazina A, Dugi D, Shariat SF, et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004; 171:1830-1834. (Pubitemid 38501015)
9. Abol-Enein H, El-Baz M, Abd El-Hameed MA, et al. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 2004; 172:1818-1821. (Pubitemid 39363063)
10. Jensen JB, Ulhoi BP, Jensen KM. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery. BJU Int 2010;106:199-205.
11. Kessler TM, Burkhard FC, Studer UE. Clinical indications and outcomes with nerve-sparing cystectomy in patients with bladder cancer. Urol Clin North Am 2005; 32:165-175. (Pubitemid 40603291)
12. Dangle PP, Gong MC, Bahnson RR, Pohar KS. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 2010;183:499-503.
13. Skinner EC, Stein JP, Skinner DG. Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 2007; 25:66-71. (Pubitemid 46027618)
14. Baltaci S,Adsan O, Ugurlu O, et al. Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology. BJU Int 2010. [Epub ahead of print]
15. Ghazi A, Zimmermann R, Al-Bodour A, et al. Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy. Eur Urol 2010;57:71-78.
16. Finelli A, Gill IS, Desai MM, et al. Laparoscopic extended pelvic lymphade-nectomy for bladder cancer: technique and initial outcomes. J Urol 2004; 172:1809-1812. (Pubitemid 39363060)
17. Fang AC, Ahmad AE, Whitson JM, et al. Effectofaminimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 2010; 116:1901-1908.
18. Schumacher MC, Jonsson MN, Wiklund NP. Does extended lymphadenect-omy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer? Curr Opin Urol 2009; 19:527-532.
19. Hellenthal NJ, Hussain A, Andrews PE, et al. Lymphadenectomy atthetime of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU Int 2010. [Epub ahead of print]
20. Kondo T, Hashimoto Y, Kobayashi H, et al. Template-based lymphadenect-omy in urothelial carcinoma of the upper urinary tract: Impact on patient survival. Int J Urol 2010; 17:848-854.
21. Roscigno M, Shariat SF, Margulis V, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 2009; 56:512-518.
22. Kondo T, Nakazawa H, Ito F, et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 2007; 69:265-269. (Pubitemid 46274933)
23. Roscigno M, Shariat SF, Margulis V, et al. Impact of lymph nodedissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 2009; 181:2482-2489.
24. Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 2010; 75:118-124.
25. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
26. Capitanio U, Jeldres C, Patard JJ, et al. Stage-specific effect of nodal metastases on survival in patients with nonmetastatic renal cell carcinoma. BJU Int 2009; 103:33-37.
27. Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 2009; 55:28-34.
28. Nguyen MM, Gill IS. Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol 2009; 181:1020-1027; discussion 1027.
29. Johnsen JA, Hellsten S. Lymphatogenous spread of renal cell carcinoma: an autopsystudy. J Urol 1997; 157:450-453. (Pubitemid 27026814)
30. Freedland SJ, Dekernion JB. Role of lymphadenectomy for patients under-going radical nephrectomy for renal cell carcinoma. Rev Urol 2003; 5:191-195.
31. Phillips CK, Taneja SS. The role of lymphadenectomy in the surgical manage-ment of renal cell carcinoma. Urol Oncol 2004; 22:214-223; discussion 223-224. (Pubitemid 38950630)
32. Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990; 144:243-245. (Pubitemid 20255089)
33. Delacroix SE Jr, Wood CG. The role of lymphadenectomy in renal cell carcinoma. Curr Opin Urol 2009; 19:465-472.
34. Assouad J, Riquet M, Foucault C, et al. Renal lymphaticdrainage andthoracic ductconnections: implicationsforcancerspread. Lymphology 2006; 39:26-32.
35. Bex A, Vermeeren L, de Windt G, et al. Feasibility of sentinel nodedetection in renal cell carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 2010; 37:1117-1123.
36. Parker AE. Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genitourinary system. Am J Anat 1935; 56:409-443.
37. Karakiewicz PI, Trinh QD, Bhojani N, et al. Renal cell carcinoma with nodal metastases in the absence ofdistant metastatic disease: prognostic indica-tors of disease-specific survival. Eur Urol 2007; 51:1616-1624. (Pubitemid 46634745)